Neuromeka뉴로메카
348340 · KOSDAQ · ₩348340 · 뉴로메카
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
With these assumptions the model gives no positive value.
- Enterprise value
- −₩166B
- Equity value
- −₩198B
- WACC
- 8.9%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model gives no positive value at these assumptions. What we can see:
- No operating margin up to 90% gets the model to today's price at these growth assumptions.
- Margins ranged from −107.9% to −75.2% over the last 4 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- —
- Base
- —
- Bull
- —
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (−20.0%).
Revenue growth
- 24.8%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (24.8% a year, annual reports), fading to 3% by year 5.
- 19.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (24.8% a year, annual reports), fading to 3% by year 5.
- 13.9%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (24.8% a year, annual reports), fading to 3% by year 5.
- 8.4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (24.8% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (24.8% a year, annual reports), fading to 3% by year 5.
Business
- -20%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 4 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 9.9%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 98%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- -10%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.08%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-29.
- 0.96
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.94, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.58%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩18B
- Net debt (borrowings and leases − cash and deposits)
- ₩38B
- + Stakes and investments
- ₩6.9B
- Associates, long-term financial assets and deposits (book value)
- − Minority interests
- ₩723M
- Shares
- 23,408,424
- Share price
- ₩17,210
- Market cap
- ₩403B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩14B | ₩25B | ₩19B | ₩23B | ₩27B | ₩31B | ₩33B | ₩34B |
| Growth | 40.9% | 83.9% | −25.0% | 24.8% | 19.3% | 13.9% | 8.4% | 3.0% |
| EBIT | −₩15B | −₩19B | −₩15B | −₩4.5B | −₩5.4B | −₩6.2B | −₩6.7B | −₩6.9B |
| EBIT margin | −107.9% | −75.2% | −78.4% | −20.0% | −20.0% | −20.0% | −20.0% | −20.0% |
| After-tax EBIT | −₩11B | −₩14B | −₩11B | −₩3.3B | −₩3.9B | −₩4.5B | −₩4.8B | −₩5B |
| + Depreciation | ₩901M | ₩2.2B | ₩2.7B | ₩2.2B | ₩2.7B | ₩3B | ₩3.3B | ₩3.4B |
| − Capital spending | ₩31B | ₩14B | ₩3.2B | ₩22B | ₩26B | ₩30B | ₩33B | ₩34B |
| − Working capital | −₩26B | −₩8.2B | −₩19B | −₩450M | −₩437M | −₩376M | −₩259M | −₩100M |
| Free cash flow | −₩15B | −₩17B | ₩7.8B | −₩23B | −₩27B | −₩31B | −₩34B | −₩35B |
| Discount factor | — | — | — | 0.918 | 0.843 | 0.774 | 0.711 | 0.653 |
| Present value | — | — | — | −₩21B | −₩23B | −₩24B | −₩24B | −₩23B |
Terminal value −₩78B, worth −₩51B today: 31% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩1,554 a share)Now 11.1× | ₩18,64412.0× | ₩28,05718.1× | ₩55,59235.8× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2023, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 7.9% | — | — | — | — | — |
| 8.4% | — | — | — | — | — |
| 8.9% | — | — | — | — | — |
| 9.4% | — | — | — | — | — |
| 9.9% | — | — | — | — | — |
Now (TTM)
- Market cap
- ₩403B
- Enterprise value
- ₩440B
- P/E
- —
- P/B
- 11.1×
- P/S
- 22.2×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Price | ₩20,900 | ₩18,264 | ₩23,600 | ₩7,909 |
| Market cap | ₩489B | ₩428B | ₩552B | ₩185B |
| P/E | — | — | — | — |
| P/B | 35.2× | 39.3× | 23.0× | 4.7× |
| P/S | 25.8× | 16.9× | 40.2× | 19.0× |
| EV/EBITDA | — | — | — | — |
| Dividend yield | 0.0% | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Neuromeka | — | 11.1× | 22.2× | — | 0.0% |
| Doosan Enerbility | 200.6× | 4.5× | 2.0× | — | 0.0% |
| Hanmi Semiconductor | 84.5× | 25.1× | 34.0× | 76.1× | 0.4% |
| Jusung Engineering | 1,135.2× | 13.9× | 36.4× | 2,185.7× | 0.0% |
| Rainbow Robotics | 4,308.5× | 55.2× | 162.6× | — | 0.0% |
| EO Technics | 47.1× | 6.8× | 11.5× | — | 0.0% |
| Doosan Bobcat | 13,805.1× | 923.8× | 743.7× | — | 3.5% |
| Similar companies (median) | 667.9× | 19.5× | 35.2× | 1,130.9× | 0.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Neuromeka / 뉴로메카 / 348340 / KRX:348340
Source: KRX statistical information